
Sean E. Aeder
Examiner (ID: 2139, Phone: (571)272-8787 , Office: P/1642 )
| Most Active Art Unit | 1642 |
| Art Unit(s) | 1642 |
| Total Applications | 1939 |
| Issued Applications | 907 |
| Pending Applications | 201 |
| Abandoned Applications | 855 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 7211594
[patent_doc_number] => 20050054017
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-03-10
[patent_title] => 'Phosphospecific PAK antibodies and diagnostic kits'
[patent_app_type] => utility
[patent_app_number] => 10/716936
[patent_app_country] => US
[patent_app_date] => 2003-11-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 6934
[patent_no_of_claims] => 62
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0054/20050054017.pdf
[firstpage_image] =>[orig_patent_app_number] => 10716936
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/716936 | Phosphospecific PAK antibodies and diagnostic kits | Nov 19, 2003 | Abandoned |
Array
(
[id] => 4512910
[patent_doc_number] => 07910295
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-03-22
[patent_title] => 'Detection of micro metastasis of melanoma and breast cancer in paraffin-embedded tumor draining lymph nodes by multimarker quantitative RT-PCR'
[patent_app_type] => utility
[patent_app_number] => 10/713808
[patent_app_country] => US
[patent_app_date] => 2003-11-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 7
[patent_no_of_words] => 11732
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 125
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/910/07910295.pdf
[firstpage_image] =>[orig_patent_app_number] => 10713808
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/713808 | Detection of micro metastasis of melanoma and breast cancer in paraffin-embedded tumor draining lymph nodes by multimarker quantitative RT-PCR | Nov 13, 2003 | Issued |
Array
(
[id] => 5010817
[patent_doc_number] => 20070281296
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-12-06
[patent_title] => 'Nucleic Acids Isolated From Stage 4 Nueroblastoma'
[patent_app_type] => utility
[patent_app_number] => 10/533158
[patent_app_country] => US
[patent_app_date] => 2003-10-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11117
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0281/20070281296.pdf
[firstpage_image] =>[orig_patent_app_number] => 10533158
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/533158 | Nucleic acids isolated from stage 4 neuroblastoma | Oct 29, 2003 | Issued |
Array
(
[id] => 5699615
[patent_doc_number] => 20060216299
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-09-28
[patent_title] => 'Cell cycle targets and peptides'
[patent_app_type] => utility
[patent_app_number] => 10/531492
[patent_app_country] => US
[patent_app_date] => 2003-10-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 30637
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0216/20060216299.pdf
[firstpage_image] =>[orig_patent_app_number] => 10531492
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/531492 | Cell cycle targets and peptides | Oct 29, 2003 | Abandoned |
Array
(
[id] => 5631594
[patent_doc_number] => 20060148064
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-07-06
[patent_title] => 'Apparatus and method for immunotherapy of a cancer through controlled cell lysis'
[patent_app_type] => utility
[patent_app_number] => 10/532660
[patent_app_country] => US
[patent_app_date] => 2003-10-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 18796
[patent_no_of_claims] => 44
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0148/20060148064.pdf
[firstpage_image] =>[orig_patent_app_number] => 10532660
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/532660 | Apparatus and method for immunotherapy of a cancer through controlled cell lysis | Oct 26, 2003 | Abandoned |
Array
(
[id] => 7307493
[patent_doc_number] => 20040141990
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-07-22
[patent_title] => 'Metastic colorectal cancer vaccine'
[patent_app_type] => new
[patent_app_number] => 10/695578
[patent_app_country] => US
[patent_app_date] => 2003-10-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7447
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0141/20040141990.pdf
[firstpage_image] =>[orig_patent_app_number] => 10695578
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/695578 | Metastatic colorectal cancer vaccine | Oct 26, 2003 | Issued |
Array
(
[id] => 7688904
[patent_doc_number] => 20070105794
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-05-10
[patent_title] => 'Immunotherapy'
[patent_app_type] => utility
[patent_app_number] => 10/531002
[patent_app_country] => US
[patent_app_date] => 2003-10-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 10272
[patent_no_of_claims] => 49
[patent_no_of_ind_claims] => 26
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0105/20070105794.pdf
[firstpage_image] =>[orig_patent_app_number] => 10531002
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/531002 | Immunotherapy | Oct 9, 2003 | Abandoned |
Array
(
[id] => 7304303
[patent_doc_number] => 20040115714
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-06-17
[patent_title] => 'Gene BRCC-2 and diagnostic and therapeutic uses thereof'
[patent_app_type] => new
[patent_app_number] => 10/679865
[patent_app_country] => US
[patent_app_date] => 2003-10-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 13244
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 19
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0115/20040115714.pdf
[firstpage_image] =>[orig_patent_app_number] => 10679865
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/679865 | Gene BRCC-2 and diagnostic and therapeutic uses thereof | Oct 5, 2003 | Issued |
Array
(
[id] => 5866012
[patent_doc_number] => 20060100143
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-05-11
[patent_title] => 'Polypeptide'
[patent_app_type] => utility
[patent_app_number] => 10/522043
[patent_app_country] => US
[patent_app_date] => 2003-10-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 12533
[patent_no_of_claims] => 54
[patent_no_of_ind_claims] => 14
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0100/20060100143.pdf
[firstpage_image] =>[orig_patent_app_number] => 10522043
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/522043 | Polypeptide | Oct 2, 2003 | Abandoned |
Array
(
[id] => 7591166
[patent_doc_number] => 07662917
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-02-16
[patent_title] => 'Human sarcoma-associated antigens'
[patent_app_type] => utility
[patent_app_number] => 10/529655
[patent_app_country] => US
[patent_app_date] => 2003-09-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 7
[patent_no_of_words] => 38313
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/662/07662917.pdf
[firstpage_image] =>[orig_patent_app_number] => 10529655
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/529655 | Human sarcoma-associated antigens | Sep 29, 2003 | Issued |
Array
(
[id] => 7235253
[patent_doc_number] => 20050262577
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-11-24
[patent_title] => 'Polypeptides and nucleic acids encoding these and their use for the prevention, diagnosis or treatment of liver disorders and epithelial cancer'
[patent_app_type] => utility
[patent_app_number] => 10/528031
[patent_app_country] => US
[patent_app_date] => 2003-09-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 39588
[patent_no_of_claims] => 65
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0262/20050262577.pdf
[firstpage_image] =>[orig_patent_app_number] => 10528031
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/528031 | Polypeptides and nucleic acids encoding these and their use for the prevention, diagnosis or treatment of liver disorders and epithelial cancer | Sep 22, 2003 | Abandoned |
Array
(
[id] => 4663538
[patent_doc_number] => 20080254445
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-10-16
[patent_title] => 'Prognosis in Cancer Patients Vaccinated with a Cancer Antigen Peptide-Associated Agent'
[patent_app_type] => utility
[patent_app_number] => 10/571908
[patent_app_country] => US
[patent_app_date] => 2003-09-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 5836
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0254/20080254445.pdf
[firstpage_image] =>[orig_patent_app_number] => 10571908
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/571908 | Prognosis in Cancer Patients Vaccinated with a Cancer Antigen Peptide-Associated Agent | Sep 21, 2003 | Abandoned |
Array
(
[id] => 7386494
[patent_doc_number] => 20040180389
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-09-16
[patent_title] => 'Lectin compositions and methods for modulating an immune response to an antigen'
[patent_app_type] => new
[patent_app_number] => 10/667166
[patent_app_country] => US
[patent_app_date] => 2003-09-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 218021
[patent_no_of_claims] => 77
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 162
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0180/20040180389.pdf
[firstpage_image] =>[orig_patent_app_number] => 10667166
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/667166 | Lectin compositions and methods for modulating an immune response to an antigen | Sep 18, 2003 | Abandoned |
Array
(
[id] => 5747804
[patent_doc_number] => 20060110735
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-05-25
[patent_title] => 'Use of molecular markers for the preclinical and clinical profiling of inhibitors of enzymes having histone deacetylase activity'
[patent_app_type] => utility
[patent_app_number] => 10/528104
[patent_app_country] => US
[patent_app_date] => 2003-09-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 10531
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0110/20060110735.pdf
[firstpage_image] =>[orig_patent_app_number] => 10528104
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/528104 | Use of molecular markers for the preclinical and clinical profiling of inhibitors of enzymes having histone deacetylase activity | Sep 17, 2003 | Abandoned |
Array
(
[id] => 7475292
[patent_doc_number] => 20040097703
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-05-20
[patent_title] => 'Wt1 modified peptide'
[patent_app_type] => new
[patent_app_number] => 10/471835
[patent_app_country] => US
[patent_app_date] => 2003-09-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 4343
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0097/20040097703.pdf
[firstpage_image] =>[orig_patent_app_number] => 10471835
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/471835 | Wt1 modified peptide | Sep 14, 2003 | Abandoned |
Array
(
[id] => 7024910
[patent_doc_number] => 20050019304
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-01-27
[patent_title] => 'Novel human mage-like protein'
[patent_app_type] => utility
[patent_app_number] => 10/658884
[patent_app_country] => US
[patent_app_date] => 2003-09-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 18124
[patent_no_of_claims] => 57
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0019/20050019304.pdf
[firstpage_image] =>[orig_patent_app_number] => 10658884
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/658884 | Novel human mage-like protein | Sep 8, 2003 | Abandoned |
Array
(
[id] => 7427912
[patent_doc_number] => 20040161760
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-08-19
[patent_title] => 'Method of molecular diagnosis of chronic myelogenous leukemia'
[patent_app_type] => new
[patent_app_number] => 10/468406
[patent_app_country] => US
[patent_app_date] => 2003-09-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 8514
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0161/20040161760.pdf
[firstpage_image] =>[orig_patent_app_number] => 10468406
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/468406 | Method of molecular diagnosis of chronic myelogenous leukemia | Sep 1, 2003 | Abandoned |
Array
(
[id] => 5720750
[patent_doc_number] => 20060073525
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-04-06
[patent_title] => 'Methods for detecting breast and ovarian cancer'
[patent_app_type] => utility
[patent_app_number] => 10/526029
[patent_app_country] => US
[patent_app_date] => 2003-08-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 23004
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0073/20060073525.pdf
[firstpage_image] =>[orig_patent_app_number] => 10526029
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/526029 | Methods for detecting breast and ovarian cancer | Aug 27, 2003 | Abandoned |
Array
(
[id] => 7264705
[patent_doc_number] => 20040151693
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-08-05
[patent_title] => 'Use of mullerian inhibiting substance and interferon for treating tumors'
[patent_app_type] => new
[patent_app_number] => 10/646784
[patent_app_country] => US
[patent_app_date] => 2003-08-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 22161
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0151/20040151693.pdf
[firstpage_image] =>[orig_patent_app_number] => 10646784
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/646784 | Use of mullerian inhibiting substance and interferon for treating tumors | Aug 24, 2003 | Abandoned |
Array
(
[id] => 5056861
[patent_doc_number] => 20070059783
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-03-15
[patent_title] => 'Method of identifying markers diagnostic of disease and uses therefor in the diagnosis of cancer'
[patent_app_type] => utility
[patent_app_number] => 10/528745
[patent_app_country] => US
[patent_app_date] => 2003-08-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 17421
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0059/20070059783.pdf
[firstpage_image] =>[orig_patent_app_number] => 10528745
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/528745 | Method of identifying markers diagnostic of disease and uses therefor in the diagnosis of cancer | Aug 19, 2003 | Abandoned |